INSILICO MEDICINE APPLIES AI TO REVOLUTIONIZE DRUG DISCOVERY

Insilico Medicine is leveraging artificial intelligence to transform drug discovery and longevity research, according to founder and CEO Alex Zhavoronkov. The company presented its approach at the JPMorgan Global China Summit in Shanghai.